However, a wide range of studies have demonstrated that the levels of beta-2-microglobulin in the blood are significantly elevated in patients with renal disease, hematological malignancies, several solid tumors, and autoimmune diseases (discussed in [38]). The gene discussed is B2M; the disease is kidney disorder.